Literature DB >> 24042259

Plk1: unexpected roles in DNA replication.

Ranadip Mandal1, Klaus Strebhardt.   

Abstract

FOR20, a conserved centrosomal protein, is essential for Plk1 to localize to the centrosome during the S phase and regulate DNA replication. The absence of either Plk1 or FOR20 can stall the cell cycle by a previously unknown intra-S phase centrosomal checkpoint.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24042259      PMCID： PMC3817549          DOI： 10.1038/cr.2013.130

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  12 in total

Review 1.  DNA replication and progression through S phase.

Authors:  David Y Takeda; Anindya Dutta
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

2.  Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells.

Authors:  Birgit Spänkuch-Schmitt; Jürgen Bereiter-Hahn; Manfred Kaufmann; Klaus Strebhardt
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

Review 3.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

4.  Plk1 phosphorylation of Orc2 promotes DNA replication under conditions of stress.

Authors:  Bing Song; X Shawn Liu; Korbin Davis; Xiaoqi Liu
Journal:  Mol Cell Biol       Date:  2011-09-26       Impact factor: 4.272

5.  Centrosomal protein FOR20 is essential for S-phase progression by recruiting Plk1 to centrosomes.

Authors:  Minhong Shen; Yuqi Cai; Yuehong Yang; Xiaoyi Yan; Xiaoqi Liu; Tianhua Zhou
Journal:  Cell Res       Date:  2013-09-10       Impact factor: 25.617

6.  Control of ciliogenesis by FOR20, a novel centrosome and pericentriolar satellite protein.

Authors:  Fatima Sedjaï; Claire Acquaviva; Véronique Chevrier; Jean-Paul Chauvin; Emilie Coppin; Aicha Aouane; François Coulier; Aslihan Tolun; Michel Pierres; Daniel Birnbaum; Olivier Rosnet
Journal:  J Cell Sci       Date:  2010-06-15       Impact factor: 5.285

7.  Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation.

Authors:  Hyungshin Yim; Raymond L Erikson
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

8.  Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.

Authors:  Hongchang Li; Yun Wang; Xiaoqi Liu
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

Review 9.  Targeting polo-like kinase 1 for cancer therapy.

Authors:  Klaus Strebhardt; Axel Ullrich
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

10.  Functional dynamics of Polo-like kinase 1 at the centrosome.

Authors:  Kazuhiro Kishi; Marcel A T M van Vugt; Ken-ichi Okamoto; Yasunori Hayashi; Michael B Yaffe
Journal:  Mol Cell Biol       Date:  2009-03-23       Impact factor: 4.272
View more
  15 in total

Review 1.  Polo-like kinases: structural variations lead to multiple functions.

Authors:  Sihem Zitouni; Catarina Nabais; Swadhin Chandra Jana; Adán Guerrero; Mónica Bettencourt-Dias
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

Review 2.  Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?

Authors:  Maximilian Stahl; Benjamin Y Lu; Tae Kon Kim; Amer M Zeidan
Journal:  Target Oncol       Date:  2017-08       Impact factor: 4.493

3.  Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model.

Authors:  Katherine A Waugh; Sonia M Leach; Brandon L Moore; Tullia C Bruno; Jonathan D Buhrman; Jill E Slansky
Journal:  J Immunol       Date:  2016-07-01       Impact factor: 5.422

4.  A promising gene delivery system developed from PEGylated MoS2 nanosheets for gene therapy.

Authors:  Zhongyang Kou; Xin Wang; Renshun Yuan; Huabin Chen; Qiaoming Zhi; Ling Gao; Bin Wang; Zhaoji Guo; Xiaofeng Xue; Wei Cao; Liang Guo
Journal:  Nanoscale Res Lett       Date:  2014-10-27       Impact factor: 4.703

5.  Interplay between Polo kinase, LKB1-activated NUAK1 kinase, PP1βMYPT1 phosphatase complex and the SCFβTrCP E3 ubiquitin ligase.

Authors:  Sourav Banerjee; Anna Zagórska; Maria Deak; David G Campbell; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2014-07-15       Impact factor: 3.857

6.  Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8.

Authors:  Christina Helmke; Monika Raab; Franz Rödel; Yves Matthess; Thomas Oellerich; Ranadip Mandal; Mourad Sanhaji; Henning Urlaub; Claus Rödel; Sven Becker; Klaus Strebhardt
Journal:  Cell Res       Date:  2016-06-21       Impact factor: 25.617

7.  Plk1 overexpression induces chromosomal instability and suppresses tumor development.

Authors:  Guillermo de Cárcer; Sharavan Vishaan Venkateswaran; Lorena Salgueiro; Aicha El Bakkali; Kalman Somogyi; Konstantina Rowald; Pablo Montañés; Manuel Sanclemente; Beatriz Escobar; Alba de Martino; Nicholas McGranahan; Marcos Malumbres; Rocío Sotillo
Journal:  Nat Commun       Date:  2018-08-01       Impact factor: 14.919

Review 8.  Polo-like kinase-1 in DNA damage response.

Authors:  Sun-Yi Hyun; Hyo-In Hwang; Hyo-In Hwan; Young-Joo Jang
Journal:  BMB Rep       Date:  2014-05       Impact factor: 4.778

Review 9.  A Survey of Essential Genome Stability Genes Reveals That Replication Stress Mitigation Is Critical for Peri-Implantation Embryogenesis.

Authors:  Georgia R Kafer; Anthony J Cesare
Journal:  Front Cell Dev Biol       Date:  2020-05-29

10.  Radiosensitization of Non-Small Cell Lung Cancer Cells by the Plk1 Inhibitor Volasertib Is Dependent on the p53 Status.

Authors:  Jolien Van den Bossche; Andreas Domen; Marc Peeters; Christophe Deben; Ines De Pauw; Julie Jacobs; Sven De Bruycker; Pol Specenier; Patrick Pauwels; Jan Baptist Vermorken; Filip Lardon; An Wouters
Journal:  Cancers (Basel)       Date:  2019-11-28       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.